Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to GastroEsophageal Cancer
Related studies linked through entity extraction aliases.
Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma
- Status
- COMPLETED
- Phase
- NA
Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
- Status
- TERMINATED
- Phase
- PHASE2
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Early IntraVenous Administration of Nutritional Support
- Status
- TERMINATED
- Phase
- NA
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy
- Status
- UNKNOWN
- Phase
- NA
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PREoperativ Study of Exercise Training
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA